MIR1270

Across TCGA pan-cancer cohorts, MIR1270 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR1270’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR1270 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR1270 is over-expressed in tumor, although a few such as COAD and KICH show the opposite, repressed pattern.

KIRC, LIHC, and COAD are the cancer types where MIR1270 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1270 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+1.764	<.001	11	view →
LIHC	All	All	+0.273	<.001	5	view →
COAD	All	All	−0.201	.014	3	view →
KICH	Male	All	−0.573	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MIR1270–KIRC

Open the KIRC breakdown →